Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters

BACKGROUND: Berberine (BBR), as a new medicine for hyperlipidemia, can reduce the blood lipids in patients. Mechanistic studies have shown that BBR activates the extracellular-signal regulated kinase pathway by stabilizing low-density-lipoprotein receptor mRNA. However, aside from inhibiting the int...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Transl Med
Päätekijät: Li, Xiao-Yang, Zhao, Zhen-Xiong, Huang, Min, Feng, Ru, He, Chi-Yu, Ma, Chao, Luo, Shi-Heng, Fu, Jie, Wen, Bao-Ying, Ren, Long, Shou, Jia-Wen, Guo, Fang, Chen, Yangchao, Gao, Xin, Wang, Yan, Jiang, Jian-Dong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4549888/
https://ncbi.nlm.nih.gov/pubmed/26310319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0629-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia